Cervical lesion assessment using real‐time microendoscopy image analysis in Brazil: The CLARA study

We conducted a prospective evaluation of the diagnostic performance of high‐resolution microendoscopy (HRME) to detect cervical intraepithelial neoplasia (CIN) in women with abnormal screening tests. Study participants underwent colposcopy, HRME and cervical biopsy. The prospective diagnostic perfor...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cancer Vol. 149; no. 2; pp. 431 - 441
Main Authors Hunt, Brady, Fregnani, José Humberto Tavares Guerreiro, Brenes, David, Schwarz, Richard A., Salcedo, Mila P., Possati‐Resende, Júlio César, Antoniazzi, Márcio, Oliveira Fonseca, Bruno, Santana, Iara Viana Vidigal, Macêdo Matsushita, Graziela, Castle, Philip E., Schmeler, Kathleen M., Richards‐Kortum, Rebecca
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 15.07.2021
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We conducted a prospective evaluation of the diagnostic performance of high‐resolution microendoscopy (HRME) to detect cervical intraepithelial neoplasia (CIN) in women with abnormal screening tests. Study participants underwent colposcopy, HRME and cervical biopsy. The prospective diagnostic performance of HRME using an automated morphologic image analysis algorithm was compared to that of colposcopy using histopathologic detection of CIN as the gold standard. To assess the potential to further improve performance of HRME image analysis, we also conducted a retrospective analysis assessing performance of a multi‐task convolutional neural network to segment and classify HRME images. One thousand four hundred eighty‐six subjects completed the study; 435 (29%) subjects had CIN Grade 2 or more severe (CIN2+) diagnosis. HRME with morphologic image analysis for detection of CIN Grade 3 or more severe diagnoses (CIN3+) was similarly sensitive (95.6% vs 96.2%, P = .81) and specific (56.6% vs 58.7%, P = .18) as colposcopy. HRME with morphologic image analysis for detection of CIN2+ was slightly less sensitive (91.7% vs 95.6%, P < .01) and specific (59.7% vs 63.4%, P = .02) than colposcopy. Images from 870 subjects were used to train a multi‐task convolutional neural network‐based algorithm and images from the remaining 616 were used to validate its performance. There were no significant differences in the sensitivity and specificity of HRME with neural network analysis vs colposcopy for detection of CIN2+ or CIN3+. Using a neural network‐based algorithm, HRME has comparable sensitivity and specificity to colposcopy for detection of CIN2+. HRME could provide a low‐cost, point‐of‐care alternative to colposcopy and biopsy in the prevention of cervical cancer. What's new? Mobile cervical cancer screening programs that travel to rural areas can improve access to screenings, but it remains difficult for women who screen positive to access diagnostic follow‐up. In this prospective study, the authors evaluated a low‐cost, point of care diagnostic alternative to colposcopy. High‐resolution microendoscopy (HRME) was shown to be equal in sensitivity and specificity to colposcopy for detection of high grade cervical neoplasias. The images collected were used to train and evaluate a neural network‐based algorithm to classify the neoplasias, improving diagnostic performance. Using HRME as an alternative to colposcopy could improve preventive care for cervical cancer.
AbstractList We conducted a prospective evaluation of the diagnostic performance of high‐resolution microendoscopy (HRME) to detect cervical intraepithelial neoplasia (CIN) in women with abnormal screening tests. Study participants underwent colposcopy, HRME and cervical biopsy. The prospective diagnostic performance of HRME using an automated morphologic image analysis algorithm was compared to that of colposcopy using histopathologic detection of CIN as the gold standard. To assess the potential to further improve performance of HRME image analysis, we also conducted a retrospective analysis assessing performance of a multi‐task convolutional neural network to segment and classify HRME images. One thousand four hundred eighty‐six subjects completed the study; 435 (29%) subjects had CIN Grade 2 or more severe (CIN2+) diagnosis. HRME with morphologic image analysis for detection of CIN Grade 3 or more severe diagnoses (CIN3+) was similarly sensitive (95.6% vs 96.2%, P = .81) and specific (56.6% vs 58.7%, P = .18) as colposcopy. HRME with morphologic image analysis for detection of CIN2+ was slightly less sensitive (91.7% vs 95.6%, P < .01) and specific (59.7% vs 63.4%, P = .02) than colposcopy. Images from 870 subjects were used to train a multi‐task convolutional neural network‐based algorithm and images from the remaining 616 were used to validate its performance. There were no significant differences in the sensitivity and specificity of HRME with neural network analysis vs colposcopy for detection of CIN2+ or CIN3+. Using a neural network‐based algorithm, HRME has comparable sensitivity and specificity to colposcopy for detection of CIN2+. HRME could provide a low‐cost, point‐of‐care alternative to colposcopy and biopsy in the prevention of cervical cancer. What's new? Mobile cervical cancer screening programs that travel to rural areas can improve access to screenings, but it remains difficult for women who screen positive to access diagnostic follow‐up. In this prospective study, the authors evaluated a low‐cost, point of care diagnostic alternative to colposcopy. High‐resolution microendoscopy (HRME) was shown to be equal in sensitivity and specificity to colposcopy for detection of high grade cervical neoplasias. The images collected were used to train and evaluate a neural network‐based algorithm to classify the neoplasias, improving diagnostic performance. Using HRME as an alternative to colposcopy could improve preventive care for cervical cancer.
We conducted a prospective evaluation of the diagnostic performance of high‐resolution microendoscopy (HRME) to detect cervical intraepithelial neoplasia (CIN) in women with abnormal screening tests. Study participants underwent colposcopy, HRME and cervical biopsy. The prospective diagnostic performance of HRME using an automated morphologic image analysis algorithm was compared to that of colposcopy using histopathologic detection of CIN as the gold standard. To assess the potential to further improve performance of HRME image analysis, we also conducted a retrospective analysis assessing performance of a multi‐task convolutional neural network to segment and classify HRME images. One thousand four hundred eighty‐six subjects completed the study; 435 (29%) subjects had CIN Grade 2 or more severe (CIN2+) diagnosis. HRME with morphologic image analysis for detection of CIN Grade 3 or more severe diagnoses (CIN3+) was similarly sensitive (95.6% vs 96.2%, P = .81) and specific (56.6% vs 58.7%, P = .18) as colposcopy. HRME with morphologic image analysis for detection of CIN2+ was slightly less sensitive (91.7% vs 95.6%, P < .01) and specific (59.7% vs 63.4%, P = .02) than colposcopy. Images from 870 subjects were used to train a multi‐task convolutional neural network‐based algorithm and images from the remaining 616 were used to validate its performance. There were no significant differences in the sensitivity and specificity of HRME with neural network analysis vs colposcopy for detection of CIN2+ or CIN3+. Using a neural network‐based algorithm, HRME has comparable sensitivity and specificity to colposcopy for detection of CIN2+. HRME could provide a low‐cost, point‐of‐care alternative to colposcopy and biopsy in the prevention of cervical cancer.
We conducted a prospective evaluation of the diagnostic performance of high-resolution microendoscopy (HRME) to detect cervical intraepithelial neoplasia (CIN) in women with abnormal screening tests. Study participants underwent colposcopy, HRME and cervical biopsy. The prospective diagnostic performance of HRME using an automated morphologic image analysis algorithm was compared to that of colposcopy using histopathologic detection of CIN as the gold standard. To assess the potential to further improve performance of HRME image analysis, we also conducted a retrospective analysis assessing performance of a multi-task convolutional neural network to segment and classify HRME images. One thousand four hundred eighty-six subjects completed the study; 435 (29%) subjects had CIN Grade 2 or more severe (CIN2+) diagnosis. HRME with morphologic image analysis for detection of CIN Grade 3 or more severe diagnoses (CIN3+) was similarly sensitive (95.6% vs 96.2%, P = .81) and specific (56.6% vs 58.7%, P = .18) as colposcopy. HRME with morphologic image analysis for detection of CIN2+ was slightly less sensitive (91.7% vs 95.6%, P < .01) and specific (59.7% vs 63.4%, P = .02) than colposcopy. Images from 870 subjects were used to train a multi-task convolutional neural network-based algorithm and images from the remaining 616 were used to validate its performance. There were no significant differences in the sensitivity and specificity of HRME with neural network analysis vs colposcopy for detection of CIN2+ or CIN3+. Using a neural network-based algorithm, HRME has comparable sensitivity and specificity to colposcopy for detection of CIN2+. HRME could provide a low-cost, point-of-care alternative to colposcopy and biopsy in the prevention of cervical cancer.We conducted a prospective evaluation of the diagnostic performance of high-resolution microendoscopy (HRME) to detect cervical intraepithelial neoplasia (CIN) in women with abnormal screening tests. Study participants underwent colposcopy, HRME and cervical biopsy. The prospective diagnostic performance of HRME using an automated morphologic image analysis algorithm was compared to that of colposcopy using histopathologic detection of CIN as the gold standard. To assess the potential to further improve performance of HRME image analysis, we also conducted a retrospective analysis assessing performance of a multi-task convolutional neural network to segment and classify HRME images. One thousand four hundred eighty-six subjects completed the study; 435 (29%) subjects had CIN Grade 2 or more severe (CIN2+) diagnosis. HRME with morphologic image analysis for detection of CIN Grade 3 or more severe diagnoses (CIN3+) was similarly sensitive (95.6% vs 96.2%, P = .81) and specific (56.6% vs 58.7%, P = .18) as colposcopy. HRME with morphologic image analysis for detection of CIN2+ was slightly less sensitive (91.7% vs 95.6%, P < .01) and specific (59.7% vs 63.4%, P = .02) than colposcopy. Images from 870 subjects were used to train a multi-task convolutional neural network-based algorithm and images from the remaining 616 were used to validate its performance. There were no significant differences in the sensitivity and specificity of HRME with neural network analysis vs colposcopy for detection of CIN2+ or CIN3+. Using a neural network-based algorithm, HRME has comparable sensitivity and specificity to colposcopy for detection of CIN2+. HRME could provide a low-cost, point-of-care alternative to colposcopy and biopsy in the prevention of cervical cancer.
We conducted a prospective evaluation of the diagnostic performance of high-resolution microendoscopy (HRME) to detect cervical intraepithelial neoplasia (CIN) in women with abnormal screening tests. Study participants underwent colposcopy, HRME, and cervical biopsy. The prospective diagnostic performance of HRME using an automated morphologic image analysis algorithm was compared to colposcopy using histopathologic detection of CIN as the gold standard. To assess the potential to further improve performance of HRME image analysis, we also conducted a retrospective analysis assessing performance of a multi-task convolutional neural network to segment and classify HRME images. 1,486 subjects completed the study; 435 (29%) subjects had CIN grade 2 or more severe (CIN2+) diagnosis. HRME with morphologic image analysis for detection of CIN grade 3 or more severe diagnoses (CIN3+) was similarly sensitive (95.6% vs. 96.2%, p=0.81) and specific (56.6% vs. 58.7%, p=0.18) as colposcopy. HRME with morphologic image analysis for detection of CIN2+ was slightly less sensitive (91.7% vs. 95.6%, p<0.01) and specific (59.7% vs. 63.4%, p=0.02) than colposcopy. Images from 870 subjects were used to train a multi-task convolutional neural network-based algorithm and images from the remaining 616 were used to validate its performance. There were no significant differences in the sensitivity and specificity of HRME with neural network analysis vs. colposcopy for detection of CIN2+ or CIN3+. Using a neural network-based algorithm, HRME has comparable sensitivity and specificity to colposcopy for detection of CIN2+. HRME could provide a low-cost, point-of-care alternative to colposcopy and biopsy in the prevention of cervical cancer.
We conducted a prospective evaluation of the diagnostic performance of high-resolution microendoscopy (HRME) to detect cervical intraepithelial neoplasia (CIN) in women with abnormal screening tests. Study participants underwent colposcopy, HRME and cervical biopsy. The prospective diagnostic performance of HRME using an automated morphologic image analysis algorithm was compared to that of colposcopy using histopathologic detection of CIN as the gold standard. To assess the potential to further improve performance of HRME image analysis, we also conducted a retrospective analysis assessing performance of a multi-task convolutional neural network to segment and classify HRME images. One thousand four hundred eighty-six subjects completed the study; 435 (29%) subjects had CIN Grade 2 or more severe (CIN2+) diagnosis. HRME with morphologic image analysis for detection of CIN Grade 3 or more severe diagnoses (CIN3+) was similarly sensitive (95.6% vs 96.2%, P = .81) and specific (56.6% vs 58.7%, P = .18) as colposcopy. HRME with morphologic image analysis for detection of CIN2+ was slightly less sensitive (91.7% vs 95.6%, P < .01) and specific (59.7% vs 63.4%, P = .02) than colposcopy. Images from 870 subjects were used to train a multi-task convolutional neural network-based algorithm and images from the remaining 616 were used to validate its performance. There were no significant differences in the sensitivity and specificity of HRME with neural network analysis vs colposcopy for detection of CIN2+ or CIN3+. Using a neural network-based algorithm, HRME has comparable sensitivity and specificity to colposcopy for detection of CIN2+. HRME could provide a low-cost, point-of-care alternative to colposcopy and biopsy in the prevention of cervical cancer.
We conducted a prospective evaluation of the diagnostic performance of high‐resolution microendoscopy (HRME) to detect cervical intraepithelial neoplasia (CIN) in women with abnormal screening tests. Study participants underwent colposcopy, HRME and cervical biopsy. The prospective diagnostic performance of HRME using an automated morphologic image analysis algorithm was compared to that of colposcopy using histopathologic detection of CIN as the gold standard. To assess the potential to further improve performance of HRME image analysis, we also conducted a retrospective analysis assessing performance of a multi‐task convolutional neural network to segment and classify HRME images. One thousand four hundred eighty‐six subjects completed the study; 435 (29%) subjects had CIN Grade 2 or more severe (CIN2+) diagnosis. HRME with morphologic image analysis for detection of CIN Grade 3 or more severe diagnoses (CIN3+) was similarly sensitive (95.6% vs 96.2%, P  = .81) and specific (56.6% vs 58.7%, P  = .18) as colposcopy. HRME with morphologic image analysis for detection of CIN2+ was slightly less sensitive (91.7% vs 95.6%, P  < .01) and specific (59.7% vs 63.4%, P  = .02) than colposcopy. Images from 870 subjects were used to train a multi‐task convolutional neural network‐based algorithm and images from the remaining 616 were used to validate its performance. There were no significant differences in the sensitivity and specificity of HRME with neural network analysis vs colposcopy for detection of CIN2+ or CIN3+. Using a neural network‐based algorithm, HRME has comparable sensitivity and specificity to colposcopy for detection of CIN2+. HRME could provide a low‐cost, point‐of‐care alternative to colposcopy and biopsy in the prevention of cervical cancer. What's new? Mobile cervical cancer screening programs that travel to rural areas can improve access to screenings, but it remains difficult for women who screen positive to access diagnostic follow‐up. In this prospective study, the authors evaluated a low‐cost, point of care diagnostic alternative to colposcopy. High‐resolution microendoscopy (HRME) was shown to be equal in sensitivity and specificity to colposcopy for detection of high grade cervical neoplasias. The images collected were used to train and evaluate a neural network‐based algorithm to classify the neoplasias, improving diagnostic performance. Using HRME as an alternative to colposcopy could improve preventive care for cervical cancer.
Author Oliveira Fonseca, Bruno
Santana, Iara Viana Vidigal
Macêdo Matsushita, Graziela
Hunt, Brady
Schwarz, Richard A.
Salcedo, Mila P.
Antoniazzi, Márcio
Castle, Philip E.
Fregnani, José Humberto Tavares Guerreiro
Schmeler, Kathleen M.
Brenes, David
Richards‐Kortum, Rebecca
Possati‐Resende, Júlio César
AuthorAffiliation 3 Federal University of Health Sciences of Porto Alegre (UFCSPA)/Santa Casa Hospital of Porto Alegre, Brazil
2 Barretos Cancer Hospital, Barretos, São Paulo, Brazil
4 Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD
1 Rice University, Department of Bioengineering, Houston, Texas
5 Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD
6 The University of Texas MD Anderson Cancer Center, Houston, Texas
AuthorAffiliation_xml – name: 6 The University of Texas MD Anderson Cancer Center, Houston, Texas
– name: 4 Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD
– name: 5 Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD
– name: 3 Federal University of Health Sciences of Porto Alegre (UFCSPA)/Santa Casa Hospital of Porto Alegre, Brazil
– name: 1 Rice University, Department of Bioengineering, Houston, Texas
– name: 2 Barretos Cancer Hospital, Barretos, São Paulo, Brazil
Author_xml – sequence: 1
  givenname: Brady
  orcidid: 0000-0002-1143-7668
  surname: Hunt
  fullname: Hunt, Brady
  organization: Rice University
– sequence: 2
  givenname: José Humberto Tavares Guerreiro
  surname: Fregnani
  fullname: Fregnani, José Humberto Tavares Guerreiro
  organization: Superintendence of Education, A.C. Camargo Cancer Center
– sequence: 3
  givenname: David
  surname: Brenes
  fullname: Brenes, David
  organization: Rice University
– sequence: 4
  givenname: Richard A.
  surname: Schwarz
  fullname: Schwarz, Richard A.
  organization: Rice University
– sequence: 5
  givenname: Mila P.
  surname: Salcedo
  fullname: Salcedo, Mila P.
  organization: The University of Texas MD Anderson Cancer Center
– sequence: 6
  givenname: Júlio César
  surname: Possati‐Resende
  fullname: Possati‐Resende, Júlio César
  organization: Barretos Cancer Hospital
– sequence: 7
  givenname: Márcio
  surname: Antoniazzi
  fullname: Antoniazzi, Márcio
  organization: Barretos Cancer Hospital
– sequence: 8
  givenname: Bruno
  surname: Oliveira Fonseca
  fullname: Oliveira Fonseca, Bruno
  organization: Barretos Cancer Hospital
– sequence: 9
  givenname: Iara Viana Vidigal
  surname: Santana
  fullname: Santana, Iara Viana Vidigal
  organization: Barretos Cancer Hospital
– sequence: 10
  givenname: Graziela
  surname: Macêdo Matsushita
  fullname: Macêdo Matsushita, Graziela
  organization: Barretos Cancer Hospital
– sequence: 11
  givenname: Philip E.
  orcidid: 0000-0003-1082-6554
  surname: Castle
  fullname: Castle, Philip E.
  organization: National Cancer Institute, National Institutes of Health
– sequence: 12
  givenname: Kathleen M.
  surname: Schmeler
  fullname: Schmeler, Kathleen M.
  organization: The University of Texas MD Anderson Cancer Center
– sequence: 13
  givenname: Rebecca
  orcidid: 0000-0003-2347-9467
  surname: Richards‐Kortum
  fullname: Richards‐Kortum, Rebecca
  email: rkortum@rice.edu
  organization: Rice University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33811763$$D View this record in MEDLINE/PubMed
BookMark eNp9kcFu1DAQhi3Uim4LB14AWeICh7R2bMcJB6QlorRoJSRUzpbXO9l65diLnRSFE4_AM_Ik9bKlgkpwskbzze9_5j9GBz54QOgZJaeUkPLMbswpY4KzR2hGSSMLUlJxgGa5RwpJWXWEjlPaEEKpIPwxOmKsplRWbIaghXhjjXbYQbLBY50SpNSDH_CYrF_jCNr9_P5jsD3g3poYwK9CMmE7YdvrNWDttZuSTdh6_Dbqb9a9xlfXgNvF_NMcp2FcTU_QYaddgqd37wn6fP7uqr0oFh_fX7bzRWE4Z6zojCQdrVlHtSiXQDveiIqwJdNQCViaSmhhGs54xY3UrMmlhNwjhHFaC8JO0Ju97nZc9rAyeYuondrG7DROKmir_u54e63W4UbVNRV1VWaBl3cCMXwZIQ2qt8mAc9pDGJMqBalF1Ui2--vFA3QTxphvsaPKhpaNrGSmnv_p6N7K7wQy8GoP5MumFKG7RyhRu3RVTlf9SjezZw9YYwc95NjyMtb9b-KrdTD9W1pdfmj3E7da5baY
CitedBy_id crossref_primary_10_1002_cam4_70728
crossref_primary_10_1038_s41746_022_00559_z
crossref_primary_10_1016_j_cobme_2023_100495
crossref_primary_10_1364_BOE_463253
crossref_primary_10_1016_j_bios_2024_116982
crossref_primary_10_3390_v16091357
crossref_primary_10_1007_s12033_024_01124_7
crossref_primary_10_1002_ijgo_15179
crossref_primary_10_1016_j_compmedimag_2022_102052
crossref_primary_10_2196_39748
crossref_primary_10_1002_cncy_22628
crossref_primary_10_1117_1_JBO_29_5_050501
crossref_primary_10_1109_TBME_2024_3379898
crossref_primary_10_3390_bios12100786
crossref_primary_10_3390_diagnostics12112771
crossref_primary_10_1186_s13027_023_00498_8
crossref_primary_10_1038_s44222_023_00135_4
Cites_doi 10.3791/2306
10.2307/2685469
10.1364/OE.15.016413
10.1016/j.jbi.2008.08.010
10.1016/j.vaccine.2012.06.095
10.1371/journal.pone.0044924
10.1016/j.ygyno.2019.06.024
10.1364/BOE.381064
10.1158/1940-6207.CAPR-12-0221
10.1007/978-3-030-00934-2_99
10.1038/s41598-020-68252-3
10.1002/cncy.21718
10.32614/RJ-2010-008
10.1200/JGO.2016.007369
10.1093/jnci/djy225
10.1186/s12916-020-01613-x
10.1016/j.ygyno.2005.07.034
10.1016/S2214-109X(19)30482-6
10.1016/j.gie.2016.03.1472
10.1016/S2214-109X(19)30527-3
10.1002/ijc.33454
10.1002/sim.4780040112
10.1159/000343046
10.1158/1940-6207.CAPR-17-0265
10.1016/S0140-6736(00)58926-0
10.1111/php.12976
10.1186/1471-2105-12-77
ContentType Journal Article
Copyright 2021 UICC
2021 UICC.
Copyright_xml – notice: 2021 UICC
– notice: 2021 UICC.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TO
7U9
H94
K9.
7X8
5PM
DOI 10.1002/ijc.33543
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
MEDLINE - Academic
DatabaseTitleList
AIDS and Cancer Research Abstracts
MEDLINE - Academic

MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0215
EndPage 441
ExternalDocumentID PMC8815862
33811763
10_1002_ijc_33543
IJC33543
Genre article
Comparative Study
Clinical Trial
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations Brazil
GeographicLocations_xml – name: Brazil
GrantInformation_xml – fundername: National Cancer Institute
  funderid: UH2/UH3 CA189910; R01 CA251911
– fundername: NCI NIH HHS
  grantid: UH3 CA189910
– fundername: NCI NIH HHS
  grantid: UH2 CA189910
– fundername: NCI NIH HHS
  grantid: R01 CA251911
GroupedDBID ---
-~X
.3N
.GA
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EMOBN
F00
F01
F04
F5P
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IH2
IX1
J0M
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RWI
RX1
RYL
SUPJJ
TEORI
UB1
UDS
V2E
V8K
V9Y
W2D
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
XG1
XPP
XV2
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TO
7U9
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
H94
K9.
7X8
5PM
ID FETCH-LOGICAL-c4433-fc70f183f1a52be1f495603b3ae65ebc65a5c943464c7a395a57eae6003418503
IEDL.DBID DR2
ISSN 0020-7136
1097-0215
IngestDate Thu Aug 21 18:13:11 EDT 2025
Fri Jul 11 03:29:54 EDT 2025
Sun Jul 13 04:22:09 EDT 2025
Wed Feb 19 02:27:52 EST 2025
Thu Apr 24 22:56:57 EDT 2025
Tue Jul 01 02:28:36 EDT 2025
Wed Jan 22 16:29:21 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords high-resolution microendoscopy
deep learning
point-of-care
diagnostic imaging
cervical cancer prevention
Language English
License 2021 UICC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4433-fc70f183f1a52be1f495603b3ae65ebc65a5c943464c7a395a57eae6003418503
Notes Funding information
National Cancer Institute, Grant/Award Numbers: UH2/UH3 CA189910, R01 CA251911
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ORCID 0000-0003-1082-6554
0000-0003-2347-9467
0000-0002-1143-7668
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/8815862
PMID 33811763
PQID 2529129767
PQPubID 105430
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8815862
proquest_miscellaneous_2508569730
proquest_journals_2529129767
pubmed_primary_33811763
crossref_primary_10_1002_ijc_33543
crossref_citationtrail_10_1002_ijc_33543
wiley_primary_10_1002_ijc_33543_IJC33543
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 15 July 2021
PublicationDateYYYYMMDD 2021-07-15
PublicationDate_xml – month: 07
  year: 2021
  text: 15 July 2021
  day: 15
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Hoboken
PublicationTitle International journal of cancer
PublicationTitleAlternate Int J Cancer
PublicationYear 2021
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2017; 3
2009; 42
2011
1985; 4
2021; 148
2016; 124
2006; 8
1943; 242
2013; 185
2011; 12
2020; 11
2020; 10
2012; 30
2007; 15
2020; 18
2020; 8
2013; 57
2020
2019
2018
2016; 84
2018; 94
1998; 52
2018; 11
2012; 7
2010; 2
2012; 5
2014; 6
2005; 99
2019; 111
2019; 154
e_1_2_10_23_1
e_1_2_10_24_1
e_1_2_10_22_1
e_1_2_10_20_1
Liu J (e_1_2_10_11_1) 2013; 185
World Health Organization (e_1_2_10_6_1) 2019
e_1_2_10_2_1
Kurman RJ (e_1_2_10_21_1) 2014
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_3_1
e_1_2_10_16_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_12_1
e_1_2_10_9_1
e_1_2_10_13_1
e_1_2_10_10_1
e_1_2_10_33_1
e_1_2_10_32_1
e_1_2_10_31_1
e_1_2_10_30_1
Rahman G (e_1_2_10_19_1) 2006; 8
e_1_2_10_29_1
e_1_2_10_27_1
e_1_2_10_28_1
e_1_2_10_25_1
e_1_2_10_26_1
References_xml – volume: 52
  start-page: 119
  issue: 2
  year: 1998
  end-page: 126
  article-title: Approximate is better than “exact” for interval estimation of binomial proportions
  publication-title: The American Statistician
– volume: 5
  start-page: 1273
  issue: 11
  year: 2012
  end-page: 1279
  article-title: A pilot study of low‐cost, high‐resolution microendoscopy as a tool for identifying women with cervical precancer
  publication-title: Cancer Prev Res (Phila)
– volume: 8
  start-page: 151
  issue: 3–4
  year: 2006
  end-page: 154
  article-title: Wound dressing where there is limitation of choice
  publication-title: Nigerian J Surg Res
– volume: 2
  start-page: 53
  issue: 1
  year: 2010
  end-page: 58
  article-title: Two‐sided exact tests and matching confidence intervals for discrete data
  publication-title: R J
– volume: 42
  start-page: 377
  issue: 2
  year: 2009
  end-page: 381
  article-title: Research electronic data capture (REDCap)—a metadata‐driven methodology and workflow process for providing translational research informatics support
  publication-title: J Biomed Inform
– volume: 4
  start-page: 87
  issue: 1
  year: 1985
  end-page: 90
  article-title: A Wilcoxon‐type test for trend
  publication-title: Stat Med
– start-page: 893
  year: 2018
  end-page: 901
– volume: 6
  year: 2014
– volume: 185
  start-page: 235
  year: 2013
  end-page: 264
  article-title: Real‐time pathology through in vivo microscopy
  publication-title: Stud Health Technol Inform
– volume: 8
  start-page: e296
  issue: 2
  year: 2020
  end-page: e304
  article-title: Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low‐resource settings: a diagnostic accuracy study
  publication-title: Lancet Glob Health
– volume: 11
  start-page: 269
  issue: 1
  year: 2020
  end-page: 280
  article-title: In vivo imaging of cervical precancer using a low‐cost and easy‐to‐use confocal microendoscope
  publication-title: Biomed Opt Express
– volume: 18
  start-page: 169
  issue: 1
  year: 2020
  article-title: The challenges of colposcopy for cervical cancer screening in LMICs and solutions by artificial intelligence
  publication-title: BMC Med
– volume: 15
  start-page: 16413
  issue: 25
  year: 2007
  end-page: 16423
  article-title: Subcellular‐resolution molecular imaging within living tissue by fiber microendoscopy
  publication-title: Opt Express
– volume: 57
  start-page: 69
  issue: 1
  year: 2013
  end-page: 74
  article-title: Could alarmingly high rates of negative diagnoses in remote rural areas be minimized with liquid‐based cytology? Preliminary results from the RODEO study team
  publication-title: Acta Cytol
– volume: 12
  start-page: 77
  issue: 1
  year: 2011
  article-title: pROC: an open‐source package for R and S+ to analyze and compare ROC curves
  publication-title: BMC Bioinformat
– volume: 7
  issue: 9
  year: 2012
  article-title: High‐resolution microendoscopy for the detection of cervical neoplasia in low‐resource settings
  publication-title: PLoS One
– volume: 84
  start-page: 834
  issue: 5
  year: 2016
  end-page: 841
  article-title: A tablet‐interfaced high‐resolution microendoscope with automated image interpretation for real‐time evaluation of esophageal squamous cell neoplasia
  publication-title: Gastrointest Endosc
– start-page: 2306
  issue: 47
  year: 2011
  article-title: High‐resolution fiber‐optic microendoscopy for in situ cellular imaging
  publication-title: J Vis Exp
– volume: 148
  start-page: 2571
  year: 2021
  end-page: 2578
  article-title: Cervical cancer prevention in El Salvador: a prospective evaluation of screening and triage strategies incorporating high‐resolution microendoscopy to detect cervical precancer
  publication-title: Int J Cancer
– volume: 3
  start-page: 572
  issue: 5
  year: 2017
  end-page: 582
  article-title: Barriers and challenges to treatment alternatives for early‐stage cervical cancer in lower‐resource settings
  publication-title: J Global Oncol
– volume: 30
  start-page: F88
  issue: Suppl 5
  year: 2012
  end-page: F99
  article-title: Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer
  publication-title: Vaccine
– year: 2020
– volume: 111
  start-page: 923
  issue: 9
  year: 2019
  end-page: 932
  article-title: An observational study of deep learning and automated evaluation of cervical images for cancer screening
  publication-title: J Natl Cancer Inst
– volume: 124
  start-page: 581
  issue: 8
  year: 2016
  end-page: 588
  article-title: Can the careHPV test performed in mobile units replace cytology for screening in rural and remote areas?
  publication-title: Cancer Cytopathol
– volume: 94
  start-page: 1308
  issue: 6
  year: 2018
  end-page: 1313
  article-title: Is proflavine exposure associated with disease progression in women with cervical dysplasia? A brief report
  publication-title: Photochem Photobiol
– volume: 10
  issue: 1
  year: 2020
  article-title: The application of deep learning based diagnostic system to cervical squamous intraepithelial lesions recognition in colposcopy images
  publication-title: Sci Rep
– year: 2019
– volume: 8
  start-page: e191
  issue: 2
  year: 2020
  end-page: e203
  article-title: Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
  publication-title: Lancet Glob Health
– volume: 11
  start-page: 359
  year: 2018
  end-page: 370
– volume: 154
  start-page: 558
  issue: 3
  year: 2019
  end-page: 564
  article-title: Low‐cost, high‐resolution imaging for detecting cervical precancer in medically‐underserved areas of Texas
  publication-title: Gynecol Oncol
– volume: 99
  start-page: S12
  issue: 3
  year: 2005
  article-title: Cervical cancer prevention—a paradigm shift?
  publication-title: Gynecol Oncol
– volume: 242
  start-page: 749
  issue: 6276
  year: 1943
  article-title: Proflavine in closed wounds
  publication-title: Lancet
– ident: e_1_2_10_17_1
  doi: 10.3791/2306
– ident: e_1_2_10_23_1
  doi: 10.2307/2685469
– ident: e_1_2_10_12_1
  doi: 10.1364/OE.15.016413
– ident: e_1_2_10_22_1
  doi: 10.1016/j.jbi.2008.08.010
– volume: 185
  start-page: 235
  year: 2013
  ident: e_1_2_10_11_1
  article-title: Real‐time pathology through in vivo microscopy
  publication-title: Stud Health Technol Inform
– ident: e_1_2_10_8_1
  doi: 10.1016/j.vaccine.2012.06.095
– ident: e_1_2_10_14_1
  doi: 10.1371/journal.pone.0044924
– ident: e_1_2_10_15_1
  doi: 10.1016/j.ygyno.2019.06.024
– ident: e_1_2_10_28_1
  doi: 10.1364/BOE.381064
– ident: e_1_2_10_13_1
  doi: 10.1158/1940-6207.CAPR-12-0221
– ident: e_1_2_10_27_1
  doi: 10.1007/978-3-030-00934-2_99
– ident: e_1_2_10_31_1
  doi: 10.1038/s41598-020-68252-3
– ident: e_1_2_10_5_1
  doi: 10.1002/cncy.21718
– ident: e_1_2_10_24_1
  doi: 10.32614/RJ-2010-008
– ident: e_1_2_10_33_1
  doi: 10.1200/JGO.2016.007369
– ident: e_1_2_10_30_1
  doi: 10.1093/jnci/djy225
– ident: e_1_2_10_32_1
  doi: 10.1186/s12916-020-01613-x
– ident: e_1_2_10_9_1
  doi: 10.1016/j.ygyno.2005.07.034
– volume-title: WHO Classification of Tumours of Female Reproductive Organs. WHO Classification of Tumours
  year: 2014
  ident: e_1_2_10_21_1
– volume: 8
  start-page: 151
  issue: 3
  year: 2006
  ident: e_1_2_10_19_1
  article-title: Wound dressing where there is limitation of choice
  publication-title: Nigerian J Surg Res
– volume-title: Accelerating the Elimination of Cervical Cancer as a Global Public Health Problem
  year: 2019
  ident: e_1_2_10_6_1
– ident: e_1_2_10_2_1
  doi: 10.1016/S2214-109X(19)30482-6
– ident: e_1_2_10_16_1
  doi: 10.1016/j.gie.2016.03.1472
– ident: e_1_2_10_10_1
  doi: 10.1016/S2214-109X(19)30527-3
– ident: e_1_2_10_29_1
  doi: 10.1002/ijc.33454
– ident: e_1_2_10_25_1
  doi: 10.1002/sim.4780040112
– ident: e_1_2_10_4_1
  doi: 10.1159/000343046
– ident: e_1_2_10_7_1
  doi: 10.1158/1940-6207.CAPR-17-0265
– ident: e_1_2_10_3_1
– ident: e_1_2_10_18_1
  doi: 10.1016/S0140-6736(00)58926-0
– ident: e_1_2_10_20_1
  doi: 10.1111/php.12976
– ident: e_1_2_10_26_1
  doi: 10.1186/1471-2105-12-77
SSID ssj0011504
Score 2.4751766
Snippet We conducted a prospective evaluation of the diagnostic performance of high‐resolution microendoscopy (HRME) to detect cervical intraepithelial neoplasia (CIN)...
We conducted a prospective evaluation of the diagnostic performance of high-resolution microendoscopy (HRME) to detect cervical intraepithelial neoplasia (CIN)...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 431
SubjectTerms Adult
Aged
Algorithms
Biopsy
Brazil
Cancer
Cervical cancer
cervical cancer prevention
Cervical Intraepithelial Neoplasia - diagnostic imaging
Cervix
Colposcopy
Computer Systems
deep learning
diagnostic imaging
Female
high‐resolution microendoscopy
Humans
Hysteroscopy - instrumentation
Image processing
Medical research
Microtechnology
Middle Aged
Neural networks
Neural Networks, Computer
Point-of-Care Systems
point‐of‐care
Prospective Studies
Radiographic Image Interpretation, Computer-Assisted - methods
Sensitivity and Specificity
Young Adult
Title Cervical lesion assessment using real‐time microendoscopy image analysis in Brazil: The CLARA study
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.33543
https://www.ncbi.nlm.nih.gov/pubmed/33811763
https://www.proquest.com/docview/2529129767
https://www.proquest.com/docview/2508569730
https://pubmed.ncbi.nlm.nih.gov/PMC8815862
Volume 149
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1LT9wwEMdHiEPFpYXSxwJFpuqBS5Y4ju2knJZVEaDCARWJQ6XI8Tpt2iWLYPcAp36EfkY-SWecR1lopaq3RJ4or_H4P8n4Z4B3Iz1KMO1QAebTOohxwA6MsCpIcicEj5TWfvrY8Yk6OIuPzuX5Auy2c2FqPkT3wY16ho_X1MFNfr3zGxpafrN9IWRMpE-q1SJBdNqho0joNATmMMBETLVUoTDa6Y6cH4seCczHdZL39asfgPafwef20uu6k-_92TTv29sHVMf_vLdleNoIUzaoPWkFFlz1HJ4cN7_eV8ENfVRBk7GjL2zMdExPRsXzXxjKz_Hdj5-0Wj27oDo_V40mNOvlhpUXGLaYaQAorKzY3pW5LcfvGbopG34cnA6YB92-gLP9D5-GB0GzRkNg41iIoLA6LDAsFNzIKHe88AmXyIVxSrrcKmmkJQadiq02IsVd7bCNuDgoFULxEharSeVeA3MyxDRfcWVTNOY2FYnhxUgoTMoMV7oH2-3bymwDMKd1NMZZjV6OMnxsmX9sPXjbmV7W1I4_GW20rzxrOu51FskoRQmk6XRbXTN2OfqPYio3mZEN6lSVYmzswavaQ7qzYMbPOcbsHug53-kMCOc931KVXz3WO0m4xPwSb9O7xt8vPDs8GvqNtX83XYeliKpxCAkqN2BxejVzb1BOTfNN329-AXWYG10
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1Z3NbtNAEIBHpUjAhf-fQIEFgcTFqe317sZIHEJKlbRJD1Ur9eauN2swJA5qE6H2xCPwILwKL8GTMLP-gVCQuPTAzdaO_LezszPrmW8Bno3VuINhh_QwnlZehBO2p7mRXie1nAehVMqVj412ZH8_2joQByvwta6FKfkQzYIbjQxnr2mA04L0-k9qaP7etDkXUb119bY9-YQB2_GrwQb27vMw3Hyz1-t71Z4Cnokizr3MKD9DNc4CLcLUBpkLEHjKtZXCpkYKLQwx02RklOYxniqLbcRxwanN53jdC3CRdhAnUv_GbgOrIteqYj77HoZ-suYY-eF686jLs98Zl_ZsZuavHrOb8javwbf6Y5WZLh_ai3naNqe_cST_l695Ha5WvjfrloPlBqzY4iZcGlXZBbfA9pzhRJGJpUVEphtsKaP6gLcMPezJ989f5vnUsimlMtpiPKPCnhOWT9EyM10xXlhesNdH-jSfvGQ4Ellv2N3tMsfyvQ375_KSd2C1mBX2HjArfJtizCpNjMKBiXlHB9mYS4w7dSBVC17U6pGYitFOW4VMkpIuHSbYTYnrphY8bUQ_lmCSPwmt1TqWVLbpOAlFGKOXp-h2T5pmtCr0q0gXdrYgGXTFZYzmvwV3S5Vs7sI5FSdLvLhaUtZGgIjlyy1F_s6RyzudQGAIja_pdPHvD54Mtnru4P6_iz6Gy_290TAZDna2H8CVkJKPiIAq1mB1frSwD9F7nKeP3KBlcHjeev0D-Wh3Vg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1Z1Lb9QwEIBHpUgVF96PhQIGgcQl28SO7QSJw7LLqtuXUEWl3oLjOG1gN1u1u0LtiZ_A_-Cv8Cv4JYydBywFiUsP3HblUV6eGc8kM58BnmUyizDtEB7m09ILccH2FNPCi1LDWECFlK59bHtHrO-FG_t8fwm-Nr0wFR-ifeFmLcP5a2vgR1m-9hMaWnzQXcZ42OxcvWlOP2G-dvJqNMDJfU7p8M27_rpXbyng6TBkzMu19HPU4jxQnKYmyF1-wFKmjOAm1YIrri0yTYRaKhbjX2lwzGJccGXzGR73ElwOhR_bfSIGuy2rykZWNfLZ9zDzEw3GyKdr7aUuLn7nItrzhZm_BsxuxRteg2_Ns6oKXT5257O0q89-w0j-Jw_zOlytI2_Sq0zlBiyZ8iasbNe1BbfA9J3bRJGxsa8QiWqhpcR2BxwQjK_H3z9_mRUTQya2kNGU2dS29ZySYoJ-maia8EKKkrw-VmfF-CVBOyT9rd5ujziS723Yu5CbvAPL5bQ094AY7psUM1ahYxQOdMwiFeQZE5h1qkDIDrxotCPRNaHdbhQyTiq2NE1wmhI3TR142ooeVViSPwmtNiqW1J7pJKGcxhjjSXu6J-0w-hT7oUiVZjq3MhiIixidfwfuVhrZnoUx25os8OByQVdbAcsrXxwpi0PHLY-igGMCjbfpVPHvF56MNvrux_1_F30MK28Hw2RrtLP5AK5QW3lk8ad8FZZnx3PzEEPHWfrImSyB9xet1j8ACIF2BQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cervical+lesion+assessment+using+real%E2%80%90time+microendoscopy+image+analysis+in+Brazil%3A+The+CLARA+study&rft.jtitle=International+journal+of+cancer&rft.au=Hunt%2C+Brady&rft.au=Jos%C3%A9+Humberto+Tavares+Guerreiro+Fregnani&rft.au=Brenes%2C+David&rft.au=Schwarz%2C+Richard+A&rft.date=2021-07-15&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0020-7136&rft.eissn=1097-0215&rft.volume=149&rft.issue=2&rft.spage=431&rft.epage=441&rft_id=info:doi/10.1002%2Fijc.33543&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon